Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neural Tube Defects | 17 | 2024 | 366 | 2.210 |
Why?
|
| Folic Acid | 15 | 2024 | 277 | 1.960 |
Why?
|
| Folate Receptor 1 | 8 | 2024 | 30 | 1.230 |
Why?
|
| Oxazines | 2 | 2024 | 27 | 1.010 |
Why?
|
| Pyridones | 2 | 2024 | 137 | 0.920 |
Why?
|
| Piperazines | 2 | 2024 | 255 | 0.890 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 2 | 2024 | 39 | 0.830 |
Why?
|
| Spinal Dysraphism | 5 | 2022 | 272 | 0.800 |
Why?
|
| Sertraline | 2 | 2020 | 44 | 0.760 |
Why?
|
| Zebrafish | 3 | 2019 | 402 | 0.670 |
Why?
|
| Autoantibodies | 6 | 2018 | 422 | 0.640 |
Why?
|
| Folic Acid Deficiency | 5 | 2024 | 47 | 0.600 |
Why?
|
| Neural Tube | 3 | 2020 | 41 | 0.590 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 121 | 0.580 |
Why?
|
| Pregnancy | 19 | 2024 | 7373 | 0.540 |
Why?
|
| Embryonic Stem Cells | 2 | 2020 | 156 | 0.540 |
Why?
|
| Neural Crest | 1 | 2017 | 52 | 0.530 |
Why?
|
| Receptors, Cell Surface | 6 | 2013 | 422 | 0.520 |
Why?
|
| Antidepressive Agents | 1 | 2017 | 316 | 0.440 |
Why?
|
| Mice | 24 | 2024 | 17596 | 0.440 |
Why?
|
| HIV Infections | 2 | 2024 | 1951 | 0.430 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2014 | 18 | 0.420 |
Why?
|
| Teratogens | 4 | 2018 | 84 | 0.420 |
Why?
|
| Gene Expression Profiling | 3 | 2012 | 1753 | 0.360 |
Why?
|
| Toxicity Tests | 3 | 2020 | 33 | 0.340 |
Why?
|
| Animals | 29 | 2024 | 33051 | 0.340 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 4429 | 0.310 |
Why?
|
| Carrier Proteins | 4 | 2010 | 1011 | 0.300 |
Why?
|
| Paroxetine | 2 | 2020 | 23 | 0.300 |
Why?
|
| Cell Line | 5 | 2020 | 2560 | 0.280 |
Why?
|
| Environmental Pollutants | 2 | 2020 | 71 | 0.270 |
Why?
|
| Valproic Acid | 4 | 2018 | 161 | 0.270 |
Why?
|
| Folate Receptors, GPI-Anchored | 5 | 2018 | 54 | 0.260 |
Why?
|
| Repressor Proteins | 2 | 2022 | 761 | 0.260 |
Why?
|
| Tacrolimus Binding Proteins | 2 | 2020 | 70 | 0.260 |
Why?
|
| Embryonic Development | 2 | 2019 | 211 | 0.250 |
Why?
|
| Vitamin B 12 | 2 | 2013 | 57 | 0.240 |
Why?
|
| Nervous System | 2 | 2004 | 120 | 0.230 |
Why?
|
| Homeodomain Proteins | 3 | 2020 | 538 | 0.230 |
Why?
|
| Epitope Mapping | 1 | 2025 | 74 | 0.230 |
Why?
|
| Fumonisins | 1 | 2004 | 2 | 0.230 |
Why?
|
| Immunoglobulin G | 4 | 2025 | 762 | 0.220 |
Why?
|
| Embryo, Nonmammalian | 3 | 2018 | 137 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 10 | 2020 | 4504 | 0.210 |
Why?
|
| Female | 24 | 2025 | 68330 | 0.200 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2025 | 204 | 0.200 |
Why?
|
| Central Nervous System | 1 | 2004 | 272 | 0.190 |
Why?
|
| Loss of Function Mutation | 2 | 2020 | 151 | 0.190 |
Why?
|
| Homocysteine | 2 | 2016 | 118 | 0.190 |
Why?
|
| Proton-Coupled Folate Transporter | 2 | 2012 | 6 | 0.190 |
Why?
|
| Pseudomonas Infections | 1 | 2023 | 111 | 0.180 |
Why?
|
| Embryo, Mammalian | 5 | 2016 | 443 | 0.180 |
Why?
|
| Anticonvulsants | 5 | 2020 | 376 | 0.180 |
Why?
|
| Wnt3A Protein | 1 | 2020 | 11 | 0.170 |
Why?
|
| Tetrahydrofolates | 1 | 2020 | 16 | 0.170 |
Why?
|
| Humans | 26 | 2025 | 126753 | 0.170 |
Why?
|
| Cerebrum | 1 | 2020 | 33 | 0.160 |
Why?
|
| Mice, Transgenic | 3 | 2018 | 2310 | 0.160 |
Why?
|
| Organotin Compounds | 1 | 2020 | 6 | 0.160 |
Why?
|
| Citalopram | 1 | 2020 | 28 | 0.160 |
Why?
|
| Mice, Inbred ICR | 1 | 2020 | 152 | 0.160 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2019 | 14 | 0.160 |
Why?
|
| Abnormalities, Drug-Induced | 3 | 2018 | 96 | 0.150 |
Why?
|
| Pneumonia | 1 | 2023 | 334 | 0.150 |
Why?
|
| Antibodies, Monoclonal | 1 | 2025 | 988 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2025 | 1131 | 0.150 |
Why?
|
| Teratogenesis | 1 | 2018 | 8 | 0.150 |
Why?
|
| Membrane Transport Proteins | 2 | 2018 | 176 | 0.150 |
Why?
|
| Dietary Supplements | 2 | 2019 | 438 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2007 | 968 | 0.140 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2018 | 34 | 0.140 |
Why?
|
| Formates | 1 | 2018 | 7 | 0.140 |
Why?
|
| Amides | 1 | 2018 | 89 | 0.140 |
Why?
|
| Nervous System Diseases | 2 | 2020 | 393 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2021 | 477 | 0.140 |
Why?
|
| Transcription Factor AP-2 | 1 | 2017 | 21 | 0.140 |
Why?
|
| Models, Animal | 1 | 2019 | 452 | 0.140 |
Why?
|
| Gene Expression | 4 | 2020 | 1482 | 0.130 |
Why?
|
| Anencephaly | 1 | 2016 | 11 | 0.120 |
Why?
|
| Thymus Gland | 2 | 2013 | 99 | 0.120 |
Why?
|
| Meningomyelocele | 1 | 2019 | 250 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2020 | 3262 | 0.120 |
Why?
|
| Cell Cycle Proteins | 1 | 2020 | 677 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2018 | 2397 | 0.120 |
Why?
|
| Cardiovascular System | 1 | 2016 | 100 | 0.120 |
Why?
|
| Blood Proteins | 1 | 2016 | 130 | 0.120 |
Why?
|
| Autoimmunity | 1 | 2016 | 172 | 0.110 |
Why?
|
| Fetoscopy | 1 | 2019 | 456 | 0.110 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2014 | 19 | 0.110 |
Why?
|
| Microarray Analysis | 2 | 2012 | 224 | 0.110 |
Why?
|
| Cell Movement | 1 | 2017 | 849 | 0.100 |
Why?
|
| Endocytosis | 1 | 2014 | 120 | 0.100 |
Why?
|
| Mice, Knockout | 8 | 2020 | 3709 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2016 | 501 | 0.100 |
Why?
|
| Glycerol-3-Phosphate O-Acyltransferase | 1 | 2012 | 1 | 0.100 |
Why?
|
| Glycerophospholipids | 1 | 2012 | 7 | 0.100 |
Why?
|
| Thymocytes | 1 | 2012 | 8 | 0.100 |
Why?
|
| Stilbenes | 1 | 2013 | 37 | 0.100 |
Why?
|
| Anti-Obesity Agents | 1 | 2013 | 44 | 0.100 |
Why?
|
| Tight Junctions | 1 | 2012 | 35 | 0.100 |
Why?
|
| PAX3 Transcription Factor | 1 | 2012 | 29 | 0.100 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2013 | 44 | 0.100 |
Why?
|
| Paired Box Transcription Factors | 1 | 2012 | 75 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 130 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2013 | 94 | 0.090 |
Why?
|
| Genomics | 1 | 2020 | 1546 | 0.090 |
Why?
|
| Blood-Brain Barrier | 1 | 2012 | 140 | 0.090 |
Why?
|
| Risk | 2 | 2016 | 729 | 0.090 |
Why?
|
| Case-Control Studies | 5 | 2020 | 3314 | 0.090 |
Why?
|
| Genetic Variation | 1 | 2018 | 1508 | 0.090 |
Why?
|
| Immunoglobulin M | 2 | 2010 | 209 | 0.090 |
Why?
|
| Diet, High-Fat | 1 | 2013 | 239 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2020 | 2337 | 0.090 |
Why?
|
| Biological Transport, Active | 3 | 2018 | 73 | 0.080 |
Why?
|
| Cleft Palate | 2 | 2011 | 214 | 0.080 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 2304 | 0.080 |
Why?
|
| Hyperhomocysteinemia | 1 | 2009 | 37 | 0.070 |
Why?
|
| Mutation | 2 | 2020 | 5941 | 0.070 |
Why?
|
| Obesity | 2 | 2013 | 2332 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1377 | 0.070 |
Why?
|
| Arsenic | 1 | 2006 | 36 | 0.060 |
Why?
|
| Risk Factors | 4 | 2020 | 10555 | 0.060 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2025 | 32 | 0.060 |
Why?
|
| Adult | 6 | 2025 | 30410 | 0.060 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2018 | 64 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2005 | 294 | 0.050 |
Why?
|
| Diabetes Complications | 1 | 2004 | 194 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2024 | 116 | 0.050 |
Why?
|
| Amikacin | 1 | 2023 | 25 | 0.050 |
Why?
|
| Heart | 1 | 2007 | 650 | 0.050 |
Why?
|
| Carnitine O-Palmitoyltransferase | 2 | 2013 | 28 | 0.050 |
Why?
|
| Maternal Exposure | 1 | 2004 | 144 | 0.050 |
Why?
|
| NIH 3T3 Cells | 1 | 2022 | 92 | 0.050 |
Why?
|
| Wnt Signaling Pathway | 1 | 2024 | 198 | 0.050 |
Why?
|
| Genetic Techniques | 1 | 2002 | 99 | 0.050 |
Why?
|
| Fever | 1 | 2004 | 309 | 0.050 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2004 | 259 | 0.050 |
Why?
|
| Organ Size | 2 | 2013 | 429 | 0.050 |
Why?
|
| Actins | 1 | 2024 | 311 | 0.050 |
Why?
|
| Genome | 1 | 2004 | 464 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2025 | 496 | 0.040 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2023 | 172 | 0.040 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2021 | 5 | 0.040 |
Why?
|
| Integrin alpha Chains | 1 | 2021 | 14 | 0.040 |
Why?
|
| HeLa Cells | 1 | 2022 | 684 | 0.040 |
Why?
|
| Neuroaxonal Dystrophies | 1 | 2020 | 16 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2023 | 358 | 0.040 |
Why?
|
| Neurulation | 1 | 2020 | 18 | 0.040 |
Why?
|
| Male | 8 | 2025 | 62543 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2016 | 1207 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 815 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2024 | 819 | 0.040 |
Why?
|
| Fibroblast Growth Factors | 1 | 2021 | 162 | 0.040 |
Why?
|
| Swine | 1 | 2023 | 1171 | 0.040 |
Why?
|
| Nervous System Malformations | 1 | 2020 | 119 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 412 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2021 | 330 | 0.040 |
Why?
|
| Gestational Age | 2 | 2016 | 1186 | 0.040 |
Why?
|
| Antigens, CD | 1 | 2021 | 415 | 0.040 |
Why?
|
| Sheep | 1 | 2019 | 224 | 0.040 |
Why?
|
| Logistic Models | 2 | 2016 | 1779 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2020 | 646 | 0.040 |
Why?
|
| Adiposity | 1 | 2020 | 204 | 0.040 |
Why?
|
| Homocystinuria | 1 | 2018 | 26 | 0.040 |
Why?
|
| Fetal Death | 1 | 2018 | 119 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2020 | 767 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 228 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2022 | 891 | 0.030 |
Why?
|
| Muscle Spasticity | 1 | 2018 | 55 | 0.030 |
Why?
|
| Teratoma | 1 | 2018 | 119 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1656 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2020 | 300 | 0.030 |
Why?
|
| DNA Damage | 1 | 2020 | 498 | 0.030 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 151 | 0.030 |
Why?
|
| DNA Repair | 1 | 2020 | 549 | 0.030 |
Why?
|
| Drug Tolerance | 1 | 2016 | 38 | 0.030 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2016 | 100 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2020 | 3586 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2013 | 1595 | 0.030 |
Why?
|
| Cell Survival | 1 | 2018 | 841 | 0.030 |
Why?
|
| Diet | 2 | 2016 | 1100 | 0.030 |
Why?
|
| Heart Defects, Congenital | 1 | 2007 | 1853 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2016 | 325 | 0.030 |
Why?
|
| China | 1 | 2016 | 277 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 376 | 0.030 |
Why?
|
| Fetus | 1 | 2018 | 578 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2020 | 2893 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1707 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2021 | 1025 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 1222 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 783 | 0.030 |
Why?
|
| Apoptosis | 1 | 2020 | 1811 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 348 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2007 | 999 | 0.030 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 2012 | 6 | 0.020 |
Why?
|
| Leucovorin | 1 | 2012 | 52 | 0.020 |
Why?
|
| Vitamin B Complex | 1 | 2012 | 39 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2012 | 365 | 0.020 |
Why?
|
| Norway | 1 | 2011 | 29 | 0.020 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2012 | 169 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 2507 | 0.020 |
Why?
|
| Erythropoiesis | 1 | 2011 | 38 | 0.020 |
Why?
|
| Pancytopenia | 1 | 2011 | 40 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 97 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2011 | 170 | 0.020 |
Why?
|
| Denmark | 1 | 2010 | 29 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2011 | 167 | 0.020 |
Why?
|
| Neurons | 1 | 2020 | 1919 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 602 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 355 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 253 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 475 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2012 | 767 | 0.020 |
Why?
|
| Maternal Age | 1 | 2010 | 129 | 0.020 |
Why?
|
| Pregnancy Trimester, First | 1 | 2010 | 118 | 0.020 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 1351 | 0.020 |
Why?
|
| Cystathionine beta-Synthase | 1 | 2009 | 14 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2011 | 309 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2018 | 2746 | 0.020 |
Why?
|
| Body Weight | 1 | 2013 | 970 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4472 | 0.020 |
Why?
|
| Methionine | 1 | 2009 | 90 | 0.020 |
Why?
|
| Cleft Lip | 1 | 2011 | 187 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2020 | 8347 | 0.020 |
Why?
|
| Base Sequence | 1 | 2011 | 2757 | 0.020 |
Why?
|
| Ephrins | 1 | 2006 | 4 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2006 | 42 | 0.020 |
Why?
|
| RNA, Antisense | 1 | 2005 | 35 | 0.010 |
Why?
|
| Biological Transport | 1 | 2006 | 327 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 27697 | 0.010 |
Why?
|
| Pharmacogenetics | 1 | 2005 | 197 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 2004 | 66 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2013 | 1705 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2004 | 153 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 2004 | 125 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 297 | 0.010 |
Why?
|
| Multigene Family | 1 | 2004 | 289 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 690 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1054 | 0.010 |
Why?
|
| Liver | 1 | 2009 | 1765 | 0.010 |
Why?
|
| Brain | 1 | 2013 | 3038 | 0.010 |
Why?
|
| Infant | 1 | 2016 | 12771 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2006 | 2537 | 0.010 |
Why?
|
| Age Factors | 1 | 2006 | 2789 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2010 | 6214 | 0.010 |
Why?
|
| Phenotype | 1 | 2005 | 4304 | 0.010 |
Why?
|